Used as a key chiral intermediate in the synthesis of pharmaceutical agents, particularly in the production of beta-blockers and other adrenergic receptor modulators with central nervous system (CNS) activity. Its stereochemistry, specifically the (R)-enantiomer, enables enhanced binding affinity to specific biological targets, improving the efficacy and reducing side effects compared to racemic mixtures. The amino and alcohol functional groups facilitate further synthetic modifications to adjust biological properties. Commonly employed in asymmetric synthesis routes where the (R)-enantiomer provides optimal pharmacological activity due to structural compatibility with neurotransmitter receptors.